Bruce Hrovat has served on the Board of Directors of Venn Therapeutics since 2016. He is a seasoned banking professional with 20 years of experience in retail, commercial, and wholesale banking, with expertise in intraday liquidity, governance, risk, and compliance.

 

Mr. Hrovat has designed future intraday liquidity risk management strategies and frameworks for some of the largest banks. As the CEO and President of INTRADAY, which provides the world's premier real-time treasury software, Mr. Hrovat implements intraday software solutions that free tens of millions of dollars annually.

 

Mr. Hrovat has served as the COO of a top 20 regional bank, and he drove nearly $400 billion of payments each day for a top 20 global transaction bank. Earlier in his career, he was responsible for driving a consistent customer experience across a network of 5,000+ Bank of America branches. 

 

Mr. Hrovat holds undergraduate degrees in economics and petroleum engineering from Marietta College. He has previously served on boards for The Clearing House (TCH) and Rhode Island Philharmonic Orchestra and Music School. TCH is the only private-sector ACH and wire operator in the United States, clearing and settling nearly $2 trillion in U.S. dollar payments each day, representing half of all commercial ACH and wire volume.